News for 'FDA'

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

Pfizer seeks approval in India for Covid vaccine

Pfizer seeks approval in India for Covid vaccine

Rediff.com6 Dec 2020

'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'

After a year, Aurobindo Pharma starts getting USFDA nod

After a year, Aurobindo Pharma starts getting USFDA nod

Rediff.com4 Jun 2012

Both the units were under the scanner of FDA since 2011.

Ranbaxy woes continue to dog Sun Pharma

Ranbaxy woes continue to dog Sun Pharma

Rediff.com29 Oct 2015

The recalled drugs were manufactured and distributed in the US by Ohm Laboratories.

Dr Reddy's files with US FDA for generic Zofran

Dr Reddy's files with US FDA for generic Zofran

Rediff.com8 May 2003

Indian drugmaker Dr Reddy's Laboratories said on Thursday it had filed an application with the US Food and Drug Administration to market a generic form of GlaxoSmithKline's anti-nausea drug Zofran.\n\n

3 Indian firms get FDA nod for sleep disorder drug

3 Indian firms get FDA nod for sleep disorder drug

Rediff.com26 Apr 2007

Ranbaxy Laboratories, Dr Reddy's Laboratories and Sun Pharma's US subsidiary Caraco Pharmaceuticals are among the 13 generic manufacturers to get first generic approvals from the US Food and Drug Administration to manufacture and market generic versi

Another big blow for Ranbaxy

Another big blow for Ranbaxy

Rediff.com22 Aug 2014

Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.

No sabotage at Toansa plant, says Ranbaxy

No sabotage at Toansa plant, says Ranbaxy

Rediff.com12 Feb 2014

Company is among the few companies in the sector getting pulled up by FDA for violations at its factories in India.

Indian drugmakers to pay higher facility fees on US hike

Indian drugmakers to pay higher facility fees on US hike

Rediff.com3 Aug 2014

The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products

Wockhardt: Recovery not in sight yet

Wockhardt: Recovery not in sight yet

Rediff.com5 Nov 2014

The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.

We will prevail: Trump hints at 2024 presidential bid

We will prevail: Trump hints at 2024 presidential bid

Rediff.com1 Mar 2021

Speaking at the Conservative Political Action Committee in Orlando, Florida on Sunday, the 74-year-old leader, who left the White House on January 20, stopped short of announcing to run for the president in 2024, although he gave enough indications that he is moving in that direction.

This simple TIP will help you fight coronavirus

This simple TIP will help you fight coronavirus

Rediff.com4 Mar 2020

Meticulous hand washing is your best bet to get rid of the grime that clings to the hand, that might harbour nasty pathogens, including the coronavirus.

'When virus is still circulating, older people are more at risk'

'When virus is still circulating, older people are more at risk'

Rediff.com6 Oct 2021

'We lost our place in being first in the epidemic, when it hit India so hard, but we were actually the epicentre of the epidemic from essentially April 2020, for almost an entire year. We had such high cases. We were the country that had the most mixed response.'

Safety concerns over Maggi noodles back to haunt Nestle

Safety concerns over Maggi noodles back to haunt Nestle

Rediff.com30 Nov 2017

This time food regulators found excess presence of ash content in Maggi

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

New York nurse first to get Covid vaccine in US

New York nurse first to get Covid vaccine in US

Rediff.com14 Dec 2020

The news comes as the United States approaches 300,000 deaths from COVID-19.

Ranbaxy gets US nod to sell Alzheimer's generic

Ranbaxy gets US nod to sell Alzheimer's generic

Rediff.com22 Sep 2010

India's largest drugmaker, Ranbaxy, will have an exclusive six-month marketing opportunity to sell a generic version of Japanese drugmaker Eisai's drug for Alzheimer's in the US.

FDA import ban: R'bxy hires ex-NY Mayor as advisor

FDA import ban: R'bxy hires ex-NY Mayor as advisor

Rediff.com18 Sep 2008

The US Food and Drug Administration has issued two warning letters to Ranbaxy claiming procedural violations at its plants in Dewas and Paonta Sahib in India. Giuliani, a high-profile Republican leader and former US attorney in Manhattan, would provide advice and review compliance issues. Ranbaxy has been accused of selling generic drugs which did not meet FDA standards.

PIX: Shocking images on cigarette packs

PIX: Shocking images on cigarette packs

Rediff.com11 Nov 2010

Should Indian cigarette packs also have photos like these to dissuade smokers? Tell us now!

US students who took Covaxin, Sputnik asked to get re-vaccinated

US students who took Covaxin, Sputnik asked to get re-vaccinated

Rediff.com4 Jun 2021

These vaccines have not yet been approved by the World Health Organization

'Why did the government delay the vaccine?'

'Why did the government delay the vaccine?'

Rediff.com14 Apr 2021

'The government had a vaccine from January.' 'The government should have given the vaccine to all population above the age of 45, right from the start.' 'Each state has its own problems, but as far as vaccine coverage in India is concerned, there have been mistakes.'

Carcinogens in Johnson baby products?

Carcinogens in Johnson baby products?

Rediff.com16 Mar 2005

The Maharashtra Food and Drug Authority has issued notice to Johnson and Johnson, as six products including baby shampoo and baby oil were found to have carcinogenic substances.

HC quashes ban on Maggi noodles, orders fresh tests

HC quashes ban on Maggi noodles, orders fresh tests

Rediff.com13 Aug 2015

The labs have been asked to submit their report within six weeks.

Gutkha worth over Rs 7 lakh seized in Maharashtra

Gutkha worth over Rs 7 lakh seized in Maharashtra

Rediff.com1 Feb 2005

The Maharashtra Food and Drug Administration seized gutkha worth over Rs 7 lakh from various parts of the state over the last two days in an effort to enforce the ban on gutkha sales.

Manikchand's mineral water under lens

Manikchand's mineral water under lens

Rediff.com23 Jul 2004

The Maharashtra Food and Drug Administration has issued a show cause notice to a Pune-based diversified group for putting 'objectionable' label in its bottled mineral water and seized water bottles worth Rs 245,000 from Aurangabad.

India's drug inspectors hard-pressed to scrutinise factories

India's drug inspectors hard-pressed to scrutinise factories

Rediff.com7 Apr 2014

There are just 1,500 drug inspectors responsible for more than 10,000 factories in India

Dr Reddy's gets warning from US health regulator

Dr Reddy's gets warning from US health regulator

Rediff.com7 Nov 2015

Dr Reddy's gets warning from US health regulator

How to DEFEAT the NEXT Pandemic

How to DEFEAT the NEXT Pandemic

Rediff.com3 Nov 2021

Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.

Booster dose of anti-Covid vax not needed at this stage: Experts

Booster dose of anti-Covid vax not needed at this stage: Experts

Rediff.com18 Sep 2021

As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.

216 cr vaccine doses to be available between Aug-Dec: Centre

216 cr vaccine doses to be available between Aug-Dec: Centre

Rediff.com13 May 2021

As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.

Raja Krishnamoorthi on why so many Indian Americans are running for office

Raja Krishnamoorthi on why so many Indian Americans are running for office

Rediff.com5 Nov 2020

With an increasing number of people from the Indian-American community playing a significant role in US elections, Congressman Raja Krishnamoorthi said there is a realisation among them that "if you don't have a seat at the table, you're on the menu -- that is why they are voting and running for office in large numbers".

What is ailing India's pharma sector?

What is ailing India's pharma sector?

Rediff.com18 Aug 2016

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

David vs Goliath: How Wockhardt plans to beat global challenge

David vs Goliath: How Wockhardt plans to beat global challenge

Rediff.com22 Jan 2018

Only 11 antibiotics in clinical trials have received qualified infectious disease product status from the US FDA, of which five are Wockhardt's drugs.

COVID-19 test should not cost more than Rs 4,500: Govt

COVID-19 test should not cost more than Rs 4,500: Govt

Rediff.com22 Mar 2020

This may include Rs 1,500 as a screening test for suspect cases and an additional Rs 3,000 for confirmation test, the guidelines said.

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Rediff.com6 May 2016

In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.

Why train travel will never be the same again

Why train travel will never be the same again

Rediff.com14 Jul 2020

The first two coaches that rolled out from the Railway Coach Factory in Kapurthala also have fixtures coated with titanium dioxide and the provision for plasma air equipment in AC ducts to sterilise interiors using ionised air. Railway Minister Piyush Goyal also indicated that the new coaches could be the new normal.